Already Registered? Log In Now Not Registered?
Complete this form to enter the webcast. Already Registered?

(* indicates required field)

Complete this form to enter the webcast.
(* indicates required field)



*Denotes required.


Securing the Supply Chain for Small-Molecule APIs and Excipients

Fri, Sep 27, 2024 11:00 AM EDT{LOCAL_TZ}

Event Overview:

In this exclusive Drug Digest video interview, Felicity Thomas, Associate Editorial Director, Pharmaceutical Technology Group, interviews experts about small-molecule APIs and excipients. During the discussion, expert(s) will run through key trends impacting small-molecule APIs and excipients, the importance of supply chain resilience, ways in which advanced manufacturing approaches can prove beneficial, and potential hurdles facing companies seeking to secure their small-molecule API and excipient supply chains.

This Episode of Drug Digest is sponsored by:
  • Ligand
  • Coatings Place
  • Adare,
  • Aprecia
  • Biovectura
  • LB Bohle
  • Actylis
  • Catalent
Key Learning Objectives:
  • Understanding small-molecule API and excipient supply chains
  • Discovering the importance of a resilient supply chain
  • Learning about the potential benefits of advanced manufacturing approaches in securing the supply chain
  • Learning about the potential hurdles that need to be overcome in securing the supply chain
Who Should Attend:
  • CDMOs
  • API manufacturers and suppliers
  • Excipient manufacturers and suppliers
  • Manufacturers
  • Developers

For any technical questions please contact Jorge de la Bandera: JdelaBandera@mjhlifesciences.com 


Kevin Webb
Kevin Webb
Chief Operating Officer
API Innovation Center

Kevin Webb is the Chief Operating Officer of the API Innovation Center where he has direct responsibility for business operations, programs, strategy and external engagement. He leads the API Innovation Center’s efforts at a national and regional level to strengthen domestic pharmaceutical manufacturing in the U.S. and is a subject matter expert and featured speaker on the importance of securing our national health security.
Kevin brings 30 years of experience in the healthcare industry with broad, cross-functional technical expertise in government affairs, communications, manufacturing, operations, sales and brand management. He is a highly respected and trusted representative of the pharmaceutical industry.
Prior to the API Innovation Center, Kevin held leadership roles at Mallinckrodt Pharmaceuticals, Sanofi Pasteur Vaccines and Memorial Medical Center, a tertiary health center in Central Illinois. He holds an MBA from the University of Illinois and a Bachelor of Science from St. Louis University.

Nigel Langley PhD MBA
Nigel Langley PhD MBA
Global Technical Director, Life Sciences
Gaylord Chemical Company LLC

Nigel Langley, Global Technical Director, Life Sciences, Gaylord Chemical Company LLC, provides technical support to the pharmaceutical industry and helps solve drug formulation challenges. Prior to joining Gaylord Chemical Nigel has held various senior technical and marketing positions with BASF and Croda International PLC. Nigel has also worked in Japan and England with Croda. He gained his Chemistry (Hons) degree and PhD (liquid crystals) from the University of Hull (UK) and an MBA from Leeds University (UK). He also took a 2- year Postdoctoral research position at Leeds University (UK) in natural product synthesis. He has over 100 scientific publications and has co- edited 3 books. Nigel is an adjunct professor at the University of Mississippi and a Fellow of the Royal Society of Chemistry (UK). In 2018 he was awarded the Industry Research Achievement Award in Excipient Technology by the IPEC Foundation. He has been a member of the Executive Committee at IPEC- Americas since 2010 and is currently Chair. Nigel is on the Medicine Maker’s Power List for 2020, 2021 & 2022.